Synapse elimination during development and disease: Immune molecules take centre stage

Biochemical Society Transactions

Volumn 38, Issue 2, 2010, Pages 476-481

  Schafer, Dorothy P ^a   Stevens, Beth ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Complement; Neurodegeneration; Neuroimmune mediator; Neuroinflammation; Retinal ganglion cell (RGC); Synaptic pruning

Indexed keywords

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CELL LOSS; DEGENERATIVE DISEASE; DISEASE COURSE; GLAUCOMA; GLIA CELL; HUMAN; IMMUNE SYSTEM; NERVE ENDING; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNAPSE; SYNAPSE ELIMINATION; SYNAPTIC POTENTIAL; ANIMAL; BIOLOGICAL MODEL; BRAIN; GLIA; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT;

AUTACOID; CYTOKINE;

ANIMALS; BRAIN; CYTOKINES; HUMANS; IMMUNE SYSTEM; INFLAMMATION MEDIATORS; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; NEUROGLIA; SYNAPSES;

EID: 77953271370     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0380476     Document Type: Review

References (47)

1. Luo, L. and O'Leary, D.D. (2005) Axon retraction and degeneration in development and disease. Annu. Rev. Neurosci. 28, 127-156
2. Low, L.K. and Cheng, H.J. (2005) A little nip and tuck: axon refinement during development and axonal injury. Curr. Opin. Neurobiol. 15, 549-556
3. Hua, J.Y. and Smith, S.J. (2004) Neural activity and the dynamics of central nervous system development. Nat. Neurosci. 7, 327-332
4. Sanes, J.R. and Lichtman, J.W. (1999) Development of the vertebrate neuromuscular junction. Annu. Rev. Neurosci. 22, 389-442
5. Selkoe, D.J. (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791
6. Smith, R., Brundin, P. and Li, J.Y. (2005) Synaptic dysfunction in Huntington's disease: a new perspective. Cell. Mol. Life Sci. 62, 1901-1912
7. Coleman, P., Federoff, H. and Kurlan, R. (2004) A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 63, 1155-1162
8. Ferrer, I. (2009) Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects. Prog. Neurobiol. 88, 89-103
9. Huh, G.S., Boulanger, L.M., Du, H., Riquelme, P.A., Brotz, T.M. and Shatz, C.J. (2000) Functional requirement for class I MHC in CNS development and plasticity. Science 290, 2155-2159
10. Stevens, B., Allen, N.J., Vazquez, L.E., Howell, G.R., Christopherson, K.S., Nouri, N., Micheva, K.D., Mehalow, A.K., Huberman, A.D., Stafford, B. et al. (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164-1178
11. Bjartmar, L., Huberman, A.D., Ullian, E.M., Renteria, R.C., Liu, X., Xu, W., Prezioso, J., Susman, M.W., Stellwagen, D., Stokes, C.C. et al. (2006) Neuronal pentraxins mediate synaptic refinement in the developing visual system. J. Neurosci. 26, 6269-6281
12. Hooks, B.M. and Chen, C. (2006) Distinct roles for spontaneous and visual activity in remodeling of the retinogeniculate synapse. Neuron 52, 281-291
13. Chen, C. and Regehr, W.G. (2000) Developmental remodeling of the retinogeniculate synapse. Neuron 28, 955-966
14. Jaubert-Miazza, L., Green, E., Lo, F.S., Bui, K., Mills, J. and Guido, W. (2005) Structural and functional composition of the developing retinogeniculate pathway in the mouse. Visual Neurosci. 22, 661-676
15. Huberman, A.D., Feller, M.B. and Chapman, B. (2008) Mechanisms underlying development of visual maps and receptive fields. Annu. Rev. Neurosci. 31, 479-509
16. Jennings, C. (1994) Developmental neurobiology: death of a synapse. Nature 372, 498-499
17. Corriveau, R.A., Huh, G.S. and Shatz, C.J. (1998) Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron 21, 505-520
18. Goddard, C.A., Butts, D.A. and Shatz, C.J. (2007) Regulation of CNS synapses by neuronal MHC class I. Proc. Natl. Acad. Sci. U.S.A. 104, 6828-6833
19. Freeman, M.R. (2005) Glial control of synaptogenesis. Cell 120, 292-293
20. Ullian, E.M., Christopherson, K.S. and Barres, B.A. (2004) Role for glia in synaptogenesis. Glia 47, 209-216
21. Stevens, B. (2008) Neuron-astrocyte signaling in the development and plasticity of neural circuits. Neurosignals 16, 278-288
22. Meyer-Franke, A., Kaplan, M.R., Pfrieger, F.W. and Barres, B.A. (1995) Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron 15, 805-819
23. Ullian, E.M., Sapperstein, S.K., Christopherson, K.S. and Barres, B.A. (2001) Control of synapse number by glia. Science 291, 657-661
24. Boulanger, L.M. (2009) Immune proteins in brain development and synaptic plasticity. Neuron 64, 93-109
25. Pickering, M. and O'Connor, J.J. (2007) Pro-inflammatory cytokines and their effects in the dentate gyrus. Prog. Brain Res. 163, 339-354
26. Syken, J., Grandpre, T., Kanold, P.O. and Shatz, C.J. (2006) PirB restricts ocular-dominance plasticity in visual cortex. Science 313, 1795-1800
27. Syken, J. and Shatz, C.J. (2003) Expression of T cell receptor β locus in central nervous system neurons. Proc. Natl. Acad. Sci. U.S.A. 100, 13048-13053
28. Bryceson, Y.T., Foster, J.A., Kuppusamy, S.P., Herkenham, M. and Long, E.O. (2005) Expression of a killer cell receptor-like gene in plastic regions of the central nervous system. J. Neuroimmunol. 161, 177-182
29. McConnell, M.J., Huang, Y.H., Datwani, A. and Shatz, C.J. (2009) H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. Proc. Natl. Acad. Sci. U.S.A. 106, 6784-6789
30. Stellwagen, D. and Malenka, R.C. (2006) Synaptic scaling mediated by glial TNF-α. Nature 440, 1054-1059
31. Beattie, E.C., Stellwagen, D., Morishita, W., Bresnahan, J.C., Ha, B.K., Von Zastrow, M., Beattie, M.S. and Malenka, R.C. (2002) Control of synaptic strength by glial TNFα. Science 295, 2282-2285
32. Cunningham, A.J., Murray, C.A., O'Neill, L.A., Lynch, M.A. and O'Connor, J.J. (1996) Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett. 203, 17-20
33. Katsuki, H., Nakai, S., Hirai, Y., Akaji, K., Kiso, Y. and Satoh, M. (1990) Interleukin-1β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur. J. Pharmacol. 181, 323-326
34. Coogan, A. and O'Connor, J.J. (1997) Inhibition of NMDA receptor-mediated synaptic transmission in the rat dentate gyrus in vitro by IL-1β. NeuroReport 8, 2107-2110
35. Kawasaki, Y., Zhang, L., Cheng, J.K. and Ji, R.R. (2008) Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1β, interleukin-6, and tumor necrosis factor-α in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci. 28, 5189-5194
36. Sommer, C. and Kress, M. (2004) Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci. Lett. 361, 184-187
37. Shankar, G.M., Li, S., Mehta, T.H., Garcia-Munoz, A., Shepardson, N.E., Smith, I., Brett, F.M., Farrell, M.A., Rowan, M.J., Lemere, C.A. et al. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842
38. Walsh, D.M., Klyubin, I., Fadeeva, J.V., Cullen, W.K., Anwyl, R., Wolfe, M.S., Rowan, M.J. and Selkoe, D.J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539
39. Selkoe, D.J. (2008) Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106-113
40. German, D.C. and Eisch, A.J. (2004) Mouse models of Alzheimer's disease: insight into treatment. Rev. Neurosci. 15, 353-369
41. Arendt, T. (2009) Synaptic degeneration in Alzheimer's disease. Acta Neuropathol. 118, 167-179
42. Davies, C.A., Mann, D.M., Sumpter, P.Q. and Yates, P.O. (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J. Neurol. Sci. 78, 151-164
43. Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.M., Iwata, N., Saido, T.C., Maeda, J., Suhara, T., Trojanowski, J.Q. and Lee, V.M. (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337-351
44. van Beek, J., Elward, K. and Gasque, P. (2003) Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann. N.Y. Acad. Sci. 992, 56-71
45. Alexander, J.J., Anderson, A.J., Barnum, S.R., Stevens, B. and Tenner, A.J. (2008) The complement cascade: Yin-Yang in neuroinflammation - neuro-protection and -degeneration. J. Neurochem. 107, 1169-1187
46. Webster, S.D., Park, M., Fonseca, M.I. and Tenner, A.J. (2000) Structural and functional evidence for microglial expression of C1qR(P), the C1q receptor that enhances phagocytosis. J. Leukocyte Biol. 67, 109-116
47. Boyett, K.W., DiCarlo, G., Jantzen, P.T., Jackson, J., O'Leary, C., Wilcock, D., Morgan, D. and Gordon, M.N. (2003) Increased fibrillar β-amyloid in response to human Clq injections into hippocampus and cortex of APP + PS1 transgenic mice. Neurochem. Res. 28, 83-93